Effect of trichosanthin on apoptosis and telomerase activity of nasopharyngeal carcinomas in nude mice

Journal of B.U.ON.

Volumn 18, Issue 3, 2013, Pages 675-682

  Kang, Min ^a   Ou, Hesheng ^a   Wang, Rensheng ^a   Liu, Wenqi ^a   Mao, Yan ^a   Tang, Anzhou ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Nasopharyngeal carcinoma; Telomerase; Trichosanthin

Indexed keywords

CYCLOPHOSPHAMIDE; PROTEIN BAX; PROTEIN BCL 2; TELOMERASE; TRICHOSANTHIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER SIZE; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; WEIGHT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL PROLIFERATION; CYCLOPHOSPHAMIDE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TELOMERASE; TRICHOSANTHIN;

EID: 84885826676     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Jeannel D, Bouvier G, Huber A. Nasopharyngeal carcinoma: an epidemiological approach to carcinogenesis. Cancer Surv 1999; 33: 125-155.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
3. Jin YC. Clinical study of trichosanthin. In: Chang HM, Yeung HW, Tso WW, Koo A (Eds): Advances in Chinese medicinal material research. Singapore: World Scientific Publications Co, 1985; pp 319-326.
4. Ding NB, Chen DJ, Li XR, Hu G. Trichosanthin inhibits growth of breast cancer cells in vitro and in vivo. J Pract Oncol 2008; 23: 310-313.
5. Wang P, Li JC. Trichosanthin-induced specific changes of cytoskeleton configuration were associated with the decreased expression level of actin and tubulin genes in apoptotic Hela cells. Life Sci 2007; 81: 1130-1140.
6. Zhang K, Xu J, Huang X et al. Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562. Cancer Chemother Pharmacol 2007; 60: 581-587.
7. Fang EF, Zhang CZ, Zhang L et al. Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis. PLoS One 2012; 7: e41592.
8. Huang Y, Song H, Hu H, Cui L, You C, Huang L. Trichosanthin inhibits DNA methyltransferase and restores methylation-silenced gene expression in human cervical cancer cells. Mol Med Report 2012; 6: 872-878.
9. Cai Y, Xiong S, Zheng Y, Luo F, Jiang P, Chu Y. Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM. Cell Mol Immunol 2011; 8: 359-367.
10. Wang P, Xu S, Zhao K, Xiao B, Guo J. Increase in cytosolic calcium maintains plasma membrane integrity through the formation of microtubule ring structure in apoptotic cervical cancer cells induced by trichosanthin. Cell Biol Int 2009; 33: 1149-1154.
11. He JF, Li JC. The growth inhibition and the apoptosis of HeLa cells induced with TCS. Acta Anatomica Sinica 2006; 37: 301-314.
12. Higuchi S, Tamura T, Oda T. Cross-talk between the pathways leading to the induction of apoptosis and the secretion of tumor necrosis factor-alpha in ricin-treated RAW 264.7 cells. J Biochem 2004; 134: 927-933.
13. Symonds EL, Konczak I, Fenech M. The Australian fruit Illawarra plum (Podocarpus elatus Endl., Podocarpaceae) inhibits telomerase, increases histone deacetylase activity and decreases proliferation of colon cancer cells. Br J Nutr 2012; 15: 1-9.
14. Lai XF, Shen CX, Wen Z et al. PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells. J Exp Clin Cancer Res 2012; 31: 12.
15. Sharma V, Koul N, Joseph C, Dixit D, Ghosh S, Sen E. HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity. J Cell Mol Med 2010; 14: 2151-2161.
16. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-673.
17. Harrington L, McPhail T, Mar V et al. A mammalian telomerase-associated protein. Science 1997; 275: 973-977.
18. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995; 269: 1267-1270.
19. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein composition of catalytically active human telomerase from immortal cells. Science 2007; 315: 1850-1853.
20. Venteicher AS, Abreu EB, Meng Z et al. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 2009; 323: 644-648.
21. Gauthier LR, Granotier C, Soria JC et al. Detection of circulating carcinoma cells by telomerase activity. Br J Cancer 2001; 84: 631-635.
22. Wang S, Zhu J. Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter. J Biol Chem 2003; 278: 18842-18850.
23. Shuyun Xu (Ed). The pharmacological experimental methodology. Beijing, People's Health Press, 1996, pp 87-89.
24. Wedge SR, Ogilvie DJ, Dukes M et al. ZD4190:An orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitunor efficacy. Cancer Res 2000; 60: 970-975.
25. Okuno S, Harada M, Yano T et al. Complete regression of xenografted human carcinomas by camptothecin analogue-carboxymethyl dextran conjugate (T-0128). Cancer Res 2000; 60: 2988-2995.
26. Zhou HB, Cai TJ, Li ML. White veratryl alcohol-induced apoptosis of human primary gastric cancer cell xenografts in nude mice. Pathophysiology 2005; 21: 528-532.
27. Ding J, Miao ZH. Drug Evaluation: guiding principles and methods. In: Yongsu Zhen (Ed): Anticancer drug research and development. Beijing, Chemical Industry Press, 2004, pp 724-727.
28. Rhyu MS. Telomeres,telomerase and immortality. J Natl Cancer Inst 1995;87:884-887.
29. Kim NW. Clinical implication of telomerase in cancer. Eur J Cancer 1997; 33: 5781-5786.
30. Khaw AK, Yong JW, Kalthur G, Hande MP. Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells. Genes Chomosomes Cancer 2012;51:961-974.
31. Spaulding-Albright N. A review of some herbs and relative products commonly used in cancer patients. J Am Diet Assoc 1997; 97: 208-213.
32. Lee KH. Novel antitumor agents from higher plants. Med Res Rev 1999; 19: 569-596.
33. Devi PU. Withania Sormnifera Dunal (A shwagandha): Potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J Exp Biol 1996; 34: 927-932.
34. Han MQ, Liu JX, Gao H. Effects of 24 Chinese medicinal herbs on nucleic acid, protein and cell cycle of human lung adenocarcinoma cell. Zhong guo Zhong xiyi Jiehe Zazhi (Chin J Integr Tradit West Med) 1995; 15: 147-149.
35. Zhang F, Cui YH, Cao P. Proliferation inhibition and induction of apoptosis of quercetin on human nasopharyngeal carcinoma HEN1 cells. Clin Otolaryngol Head Neck Surg 2007; 21: 1136-1139.
36. Mans DR, da Rocha AB, Schwartsmann G. Anti-cancer drugs discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anticancer compounds. Oncologist 2000; 5: 185-198.
37. Haraguchi M, Torii S, Matzuzawa SI et al. Apoptotic protease activating factor 1 (APAF 1)- independent cell death suppression by Bcl-2. J Exp Med 2000;191:1709-1720.
38. Kim SC, Park SY, Kang HK et al. The Cytotoxicity of Scytosiphon lomentaria Against HL-60 Promyelocytic Leukemia Cells. Cancer Biother Radiopharmac 2004; 19: 641-648.
39. Herbert BS, Wright AC, Passons CM et al. Effects of chemo-preventive and antitelomerase agents on the spontaneons immortalization of breast epithelial cells. J Natl Cancer Inst 2001; 93: 39-45.
40. Mori H, Sugie S, Yoshimi N et al. Control of cell proliferation in cancer prevention. Mut Res 1999; 16: 291-298.